Galectin 3: A new player in the pathogenesis of Parkinson’s disease

Galectin 3: A new player in the pathogenesis of Parkinson’s disease

Saved in:

Bibliographic Details
Main Authors:	Juan García-Revilla, Jose Luis Venero, José A. Rodríguez-Gómez
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2026-03-01
Series:	Neural Regeneration Research
Online Access:	https://journals.lww.com/10.4103/NRR.NRR-D-24-01410
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Galectin-3 in heart recipients
by: A. A. Ulybysheva, et al.
Published: (2019-07-01)

Comparative analysis of galectin-1, galectin-3, and galectin-8 signatures in normal and choriocarcinoma trophoblast cell lines
by: Jovanović Krivokuća Milica, et al.
Published: (2024-01-01)

GUT ENTEROBIOTA — A NEW PLAYER IN ATHEROSCLEROSIS PATHOGENESIS
by: L. V. Egshatyan, et al.
Published: (2014-12-01)

Galectins, antibodies to them and galectin-3 binding protein in systemic lupus erythematosus
by: L. V. Kondratyeva, et al.
Published: (2025-03-01)

Phosphorylated α-Synuclein-Copper Complex Formation in the Pathogenesis of Parkinson’s Disease
by: Juan Antonio Castillo-Gonzalez, et al.
Published: (2017-01-01)

The role of Galectin-1 and Galectin-3 in the mucosal immune response to Citrobacter rodentium infection.
by: Renata Curciarello, et al.
Published: (2014-01-01)

Mitochondrial Contribution to Parkinson's Disease Pathogenesis
by: Anthony H. V. Schapira, et al.
Published: (2011-01-01)

The role of galectin-1 and galectin-3 in the mechanisms of T-cell immune response dysregulation in colon cancer
by: V. S. Poletika, et al.
Published: (2020-10-01)

Galectin-1 in Cardiovascular Pathogenesis: Unraveling Dual Roles and Mechanistic Insights in Emerging Research
by: Po-Yuan Chen, et al.
Published: (2025-05-01)

Preeclampsia pathogenesis and prediction - where are we now: the focus on the role of galectins and miRNAs
by: Natasa Karadzov Orlic, et al.
Published: (2025-12-01)

Galectin-3 in heart transplant rejection and fibrosis
by: O. P. Shevchenko, et al.
Published: (2019-10-01)

Genetic Mutations and Mitochondrial Toxins Shed New Light on the Pathogenesis of Parkinson's Disease
by: Shigeto Sato, et al.
Published: (2011-01-01)

Complement Activation: An Emerging Player in the Pathogenesis of Cardiovascular Disease
by: Angela M. Carter
Published: (2012-01-01)

Determinants of alpha-synuclein pathogenesis in Parkinson’s disease
by: Oriol Bárcenas, et al.
Published: (2026-04-01)

Modern views on etiology and pathogenesis of Parkinson's disease
by: А.V. Kutsak, et al.
Published: (2016-12-01)

Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
by: Ross B. Mounsey, et al.
Published: (2011-01-01)

Fisetin-loaded nanoemulsion ameliorates lung cancer pathogenesis via downregulating cathepsin-B, galectin-3 and enolase in an in vitro setting
by: Ayeh Bani Saeid, et al.
Published: (2024-10-01)

Galectin-1 and Galectin-3 expression in colon cancer and its correlation with tumor invasion, differentiation, and metastatic spread
by: Yu. V. Kolobovnikova, et al.
Published: (2021-12-01)

Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma
by: Milan Jovanovic, et al.
Published: (2018-01-01)

GALECTIN-3 — BIOMARKER OF FIBROSIS IN PATIENTS WITH METABOLIC SYNDROME
by: O. M. Drapkina, et al.
Published: (2015-09-01)

Combining inhibition of galectin-3 with and before a therapeutic vaccination is critical for the prostate-tumor-free outcome
by: Carolina Tiraboschi, et al.
Published: (2020-10-01)

Potential Protective Role of Galectin‐3 in Airway Dilatation in Obstructive Airway Diseases
by: Mariko Kogo, et al.
Published: (2025-08-01)

Galectin-3 in the blood serum of patients with bone tumors
by: N. E. Kushlinskii, et al.
Published: (2023-07-01)

Dopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesis.
by: Alisdair McNeill, et al.
Published: (2013-01-01)

Pathogenesis, clinical features, and treatments of depression in Parkinson's disease
by: I. V. Milyukhina
Published: (2019-06-01)

Galectin-9: diverse roles in skin disease
by: Lin Wang, et al.
Published: (2025-07-01)

Lipid-Mediated Oxidative Stress and Inflammation in the Pathogenesis of Parkinson's Disease
by: Tahira Farooqui, et al.
Published: (2011-01-01)

Galectin-3: Integrator of Signaling via Hexosamine Flux
by: Mana Mohan Mukherjee, et al.
Published: (2025-07-01)

The Role of Cystatin C and Galectin-3 in Cardiorenal Syndrome
by: Nazar Ahemd Naji, et al.
Published: (2023-02-01)

GALECTIN 3 AND ALDOSTERONE IN PATIENTS WITH ATRIAL FIBRILLATION AND METABOLIC SYNDROME
by: V. A. lonin, et al.
Published: (2015-04-01)

Leveraging AI to optimize galectin-3 inhibitors for Alzheimer’s disease: How to move forwards
by: Huiyong Zhang, et al.
Published: (2025-08-01)

AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy
by: Xueyan Liu, et al.
Published: (2025-08-01)

Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma
by: Shadi Chamseddine, et al.
Published: (2024-11-01)

Unraveling the Complexity of Parkinson's Disease: Insights into Pathogenesis and Precision Interventions
by: Han Yan, et al.
Published: (2024-11-01)

RESULTS OF RESEARCH OF GALECTIN-3 AND THYROGLOBULIN IN PATIENTS WITH THYROID NODULES
by: O. S. Olifirova, et al.
Published: (2015-04-01)

Diagnostic usefulness of Galectin-3 in thyroid gland nodular lesions
by: D. I. Kebalo, et al.
Published: (2015-12-01)

Galectin-3 in recipients with kidney graft dysfunction: analysis of predictive significance
by: D. A. Velikiy, et al.
Published: (2024-09-01)

Diagnostic value of galectin-3 in heart transplant recipients with myocardial complications
by: O. P. Shevchenko, et al.
Published: (2020-04-01)

Gut dysbiosis as a potential driver of Parkinson’s and Alzheimer’s disease pathogenesis
by: Jacob M. Pfaffinger, et al.
Published: (2025-08-01)

Study of the Elevation of Galectin-3 Level in Plasma Patients with Inflammatory Bowel Disease in Babylon Province
by: Arkan Khanjar Nasrullah, et al.
Published: (2025-01-01)